Arcadia Biosciences (RKDA) Long-Term Investments (2014 - 2016)

Arcadia Biosciences (RKDA) has 3 years of Long-Term Investments data on file, last reported at $2.5 million in Q4 2016.

• Quarterly Long-Term Investments fell 87.35% year-over-year to $2.5 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $2.5 million (down 87.35% YoY) and the FY2016 annual result came in at $2.5 million, down 87.35% from the prior year.
• Long-Term Investments fell to $2.5 million in Q4 2016, from $3.5 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $19.7 million in Q4 2015 to a low of $500000.0 in Q4 2014.
• A 3-year average of $5.5 million and a median of $2.5 million in 2016 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2015 — Long-Term Investments surged 3849.6% — and 2016, when it plunged 87.35%.
• Tracing RKDA's Long-Term Investments over 3 years: stood at $500000.0 in 2014, then surged by 3849.6% to $19.7 million in 2015, then sank by 87.35% to $2.5 million in 2016.
• The last three Long-Term Investments figures came in at $2.5 million (Q4 2016), $3.5 million (Q3 2016), and $6.9 million (Q2 2016), per Business Quant data.